BFRI
Biofrontera Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · US
$0.81
−1.94%Forward multiples
Based on analyst estimates
- P/E forward
- 4.60x
- P/E 2026E
- —
- P/E 2027E
- 4.03x
- P/E 2028E
- 4.24x
- P/S forward
- 0.25x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.01x
- Price / sales
- 0.26x
- Price / cash flow
- -1.51x
Enterprise value
- Enterprise value
- $14.8M
- EV / sales
- 0.32x
- EV / EBITDA
- -2.73x
- EV / EBIT
- -3.39x
- Market cap
- $12.0M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026